Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.

Wu, Xifeng

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug 2006 - 3789-98 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2005.03.6640 doi


Adenocarcinoma--drug therapy
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--genetics
Carcinoma, Squamous Cell--drug therapy
Chemotherapy, Adjuvant
Critical Pathways
DNA-Binding Proteins--genetics
Dose Fractionation, Radiation
Esophageal Neoplasms--drug therapy
Esophagectomy--methods
Esophagogastric Junction
Female
Fluorouracil--administration & dosage
Genes, MDR
Genotype
Humans
Male
Methylenetetrahydrofolate Reductase (NADPH2)--genetics
Middle Aged
Neoadjuvant Therapy--methods
Odds Ratio
Platinum Compounds--administration & dosage
Polymorphism, Single Nucleotide
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Radiotherapy, Adjuvant
Retrospective Studies
Risk Assessment
Stomach Neoplasms--drug therapy
Survival Analysis
Taxoids--administration & dosage
Treatment Outcome
X-ray Repair Cross Complementing Protein 1